Microplastics have been detected in human reproductive fluids, with researchers finding them in 69% of female and 55% of male ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Researchers in California have developed a blood test, OvaPrint, to help detect early-stage ovarian cancer. After successful testing, OvaPrint could be commercially available in two years.

Women may crave and drink more alcohol during certain times of their menstrual cycle, a new study suggests. Researchers say ...

GSK (NYSE:GSK) reported mixed results from a Phase 3 study evaluating Zejula, or niraparib, and Jemperli, or dostarlimab, in the treatment of advanced ovarian cancer. The U.K. drugmaker said that ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...

Potential Positives. IMUNON's lead candidate, IMNN-001, has entered the pivotal Phase 3 OVATION 3 Study, indicating advancement toward a potential breakthrough treatment for advanced ovarian cancer.

The risk of developing ovarian cancer appears to jump about fourfold among women with endometriosis, compared with women who haven’t been diagnosed with the condition, a new study finds.

The calendar-tracking method, or rhythm method, is one way people monitor and record their periods, but it might not be the most accurate. That's according to a new study released Monday by the ...